152 related articles for article (PubMed ID: 15825396)
1. Evaluation of isoprinosine in experimental human rhinovirus infection.
Pachuta DM; Togo Y; Hornick RB; Schwartz AR; Tominaga S
Antimicrob Agents Chemother; 1974 Apr; 5(4):403-8. PubMed ID: 15825396
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection.
Togo Y; Schwartz AR; Hornick RB
Antimicrob Agents Chemother; 1973 Dec; 4(6):612-6. PubMed ID: 4367686
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
Waldman RH; Ganguly R
Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.
Turner RB; Dutko FJ; Goldstein NH; Lockwood G; Hayden FG
Antimicrob Agents Chemother; 1993 Feb; 37(2):297-300. PubMed ID: 8383943
[TBL] [Abstract][Full Text] [Related]
7. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial.
Sperber SJ; Hendley JO; Hayden FG; Riker DK; Sorrentino JV; Gwaltney JM
Ann Intern Med; 1992 Jul; 117(1):37-41. PubMed ID: 1317694
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial.
Eccles R; Winther B; Johnston SL; Robinson P; Trampisch M; Koelsch S
Respir Res; 2015 Oct; 16():121. PubMed ID: 26438038
[TBL] [Abstract][Full Text] [Related]
9. Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.
Beran J; Šalapová E; Špajdel M;
BMC Infect Dis; 2016 Nov; 16(1):648. PubMed ID: 27821093
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study.
Tay SK
Int J STD AIDS; 1996 Jul; 7(4):276-80. PubMed ID: 8876359
[TBL] [Abstract][Full Text] [Related]
11. Topical enviroxime against rhinovirus infection.
Levandowski RA; Pachucki CT; Rubenis M; Jackson GG
Antimicrob Agents Chemother; 1982 Dec; 22(6):1004-7. PubMed ID: 6297380
[TBL] [Abstract][Full Text] [Related]
12. Prechallenge antibodies moderate disease expression in adults experimentally exposed to rhinovirus strain hanks.
Alper CM; Doyle WJ; Skoner DP; Buchman CA; Cohen S; Gwaltney JM
Clin Infect Dis; 1998 Jul; 27(1):119-28. PubMed ID: 9675465
[TBL] [Abstract][Full Text] [Related]
13. [EFFECTIVENESS OF COMBINED TREATMENT OF HPV INFECTION].
Nejmark BA; Kondrat'eva JS; Zologina VS; Torbik DV
Urologiia; 2015; (2):39-40, 42. PubMed ID: 26237804
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challenge.
Togo Y; Durr FE; Laurenzana DA
Med Microbiol Immunol; 1977 May; 163(1):37-44. PubMed ID: 195190
[TBL] [Abstract][Full Text] [Related]
15. Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers.
Soto AJ; Hall TS; Reed SE
Antimicrob Agents Chemother; 1973 Mar; 3(3):332-4. PubMed ID: 4364175
[TBL] [Abstract][Full Text] [Related]
16. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).
al-Nakib W; Higgins PG; Barrow GI; Tyrrell DA; Andries K; Vanden Bussche G; Taylor N; Janssen PA
Antimicrob Agents Chemother; 1989 Apr; 33(4):522-5. PubMed ID: 2543283
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rhinovirus antibody titers in children with asthma exacerbations and species-specific rhinovirus infection.
Iwasaki J; Smith WA; Khoo SK; Bizzintino J; Zhang G; Cox DW; Laing IA; Le Souëf PN; Thomas WR; Hales BJ
J Allergy Clin Immunol; 2014 Jul; 134(1):25-32. PubMed ID: 24767874
[TBL] [Abstract][Full Text] [Related]
18. Effect of bovine fibroblast interferon on rhinovirus infection in calves.
Rosenquist BD; Allen GK
Am J Vet Res; 1990 Jun; 51(6):870-3. PubMed ID: 1695067
[TBL] [Abstract][Full Text] [Related]
19. Combined antiviral and antimediator treatment of rhinovirus colds.
Gwaltney JM
J Infect Dis; 1992 Oct; 166(4):776-82. PubMed ID: 1326582
[TBL] [Abstract][Full Text] [Related]
20. Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation.
Kim SR; Song JH; Ahn JH; Lee GS; Ahn H; Yoon SI; Kang SG; Kim PH; Jeon SM; Choi EJ; Shin S; Cha Y; Cho S; Kim DE; Chang SY; Ko HJ
Antiviral Res; 2018 Mar; 151():87-96. PubMed ID: 29407486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
